Insider Trading & Ownership - GRAYZEL DAVID S.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GRAYZEL DAVID S.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2024-04-09
Sale		2024-04-11
6:00 pm		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		11,882$28.15$334,4781,799,232
(Indirect)		View
2021-07-02
Purchase		2021-07-06
4:27 pm		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		535,714$14$7,499,9963,106,032
(Indirect
Direct)		View
2020-12-17
Sale(A)		2020-12-21
3:35 pm		Surface Oncology Inc.SURFGRAYZEL DAVID S.
Director		1,700,000$8.1$13,770,0002,945,453
(Indirect)		View
2020-12-17
Sale		2020-12-21
1:32 pm		Surface Oncology Inc.SURFGRAYZEL DAVID S.
Director		1,700,000$18.1$30,770,0002,945,453
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-04-01
Option Award		2024-08-14
4:05 pm		N/A
2034-03-31		Q32 Bio Inc.QTTBGRAYZEL DAVID S.
Director		2,569$13.422,569
(Direct)		View
2024-06-05
Option Award		2024-06-07
6:00 pm		N/A
2034-06-04		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		12,500$012,500
(Direct)		View
2024-03-25
Option Award		2024-03-27
5:39 pm		N/A
2034-03-24		Q32 Bio Inc.QTTBGRAYZEL DAVID S.
Director		12,767$012,767
(Direct)		View

Ownership		2024-03-27
5:24 pm		N/A
N/A		Q32 Bio Inc.QTTBGRAYZEL DAVID S.
Director		0$02,092,106
(Indirect)		View
2024-01-02
Option Award		2024-01-04
6:00 pm		N/A
2034-01-01		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		3,186$13.493,186
(Direct)		View
2023-09-08
Disposition		2023-09-08
4:00 pm		N/A
N/A		Surface Oncology Inc.SURFGRAYZEL DAVID S.
Director		2,945,453$00
(Indirect)		View
2023-06-06
Option Award		2023-06-08
6:00 pm		N/A
2033-06-05		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		12,500$012,500
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		2,654$18.082,654
(Direct)		View
2022-06-21
Option Award		2022-06-22
5:00 pm		N/A
2032-06-20		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		12,500$012,500
(Direct)		View
2022-06-08
Option Award		2022-06-10
8:00 pm		N/A
2032-06-08		Surface Oncology Inc.SURFGRAYZEL DAVID S.
Director		24,000$024,000
(Direct)		View
2022-01-03
Option Award		2022-01-05
5:15 pm		N/A
2032-01-02		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		7,317$6.567,317
(Direct)		View
2021-07-01
Option Award		2021-07-06
4:27 pm		N/A
2031-06-30		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		2,153$11.153,106,032
(Direct)		View
2021-07-02
Conversion		2021-07-06
4:27 pm		N/A
N/A		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		10,544,919$03,106,032
(Indirect)		View
2021-06-29
Option Award		2021-07-01
6:32 pm		N/A
2031-06-28		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		25,000$09,876,456
(Direct)		View
2021-02-01
Option Award		2021-07-01
6:32 pm		N/A
N/A		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		6,981,033$1.8939,876,456
(Indirect)		View

Ownership		2021-06-29
8:44 pm		N/A
N/A		Aerovate Therapeutics Inc.AVTEGRAYZEL DAVID S.
Director		0$02,568,165
(Indirect)		View
2021-06-08
Option Award		2021-06-10
4:30 pm		N/A
2031-06-08		Surface Oncology Inc.SURFGRAYZEL DAVID S.
Director		17,700$017,700
(Direct)		View
2020-06-10
Option Award		2020-06-12
08:00 am		N/A
2030-06-10		Surface Oncology Inc.SURFGRAYZEL DAVID S.
Director		12,000$012,000
(Direct)		View
(A) Indicate amendment filing.